William V Lechner1, Valerie S Knopik2, John E McGeary2, Nichea S Spillane3, Jennifer W Tidey3, Sherry A McKee4, Jane Metrik5, Adam M Leventhal6, Damaris J Rohsenow5, Christopher W Kahler3. 1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI; william_lechner@brown.edu. 2. Division of Behavioral Genetics, Rhode Island Hospital, Providence, RI; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI; 3. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI; 4. School of Medicine, Yale University, New Haven, CT; 5. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, RI; Providence Veterans Affairs Medical Center, Providence, RI; 6. Department of Preventive Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA.
Abstract
INTRODUCTION: The current study examined whether the presence of the G allele of the A118G polymorphism of the OPRM1 gene (rs1799971) and the long allele of exon 3 VNTR polymorphism of the DRD4 gene moderate the effect of alcohol administration on urge to smoke. These polymorphisms have been associated with greater alcohol induced-urge to drink. Urge to drink and alcohol consumption increase urge to smoke. Therefore, these polymorphisms may also sensitize urge to smoke after alcohol consumption. METHODS:Individuals smoking 10-30 cigarettes per day and reporting heavy drinking were recruited from the community. Caucasians (n = 62), 57.3% male, mean age 39.2, took part in a three-session, within-subjects, repeated-measures design study. Participants were administered a placebo, 0.4 g/kg, or 0.8 g/kg dose of alcohol. A118G genotype, exon 3 VNTR genotype, and urge to smoke (baseline and three times after receiving alcohol) were assessed. RESULTS: G allele carriers showed greater urge to smoke across all assessments. Additionally, a significant interaction indicated that G carriers, compared to homozygotes (AA), evinced a significantly greater increase in urge to smoke after high dose alcohol relative to placebo. The interaction between condition, DRD4 polymorphism, and time was not significant. CONCLUSIONS: Presence of G allele of the A118G polymorphism of the OPRM1 gene may lead to greater increases in urge to smoke after a high dose of alcohol. Pharmacotherapies targeted to opiate receptors (eg, naltrexone) may be especially helpful in aiding smoking cessation among G carriers who are heavy drinkers.
RCT Entities:
INTRODUCTION: The current study examined whether the presence of the G allele of the A118G polymorphism of the OPRM1 gene (rs1799971) and the long allele of exon 3 VNTR polymorphism of the DRD4 gene moderate the effect of alcohol administration on urge to smoke. These polymorphisms have been associated with greater alcohol induced-urge to drink. Urge to drink and alcohol consumption increase urge to smoke. Therefore, these polymorphisms may also sensitize urge to smoke after alcohol consumption. METHODS: Individuals smoking 10-30 cigarettes per day and reporting heavy drinking were recruited from the community. Caucasians (n = 62), 57.3% male, mean age 39.2, took part in a three-session, within-subjects, repeated-measures design study. Participants were administered a placebo, 0.4 g/kg, or 0.8 g/kg dose of alcohol. A118G genotype, exon 3 VNTR genotype, and urge to smoke (baseline and three times after receiving alcohol) were assessed. RESULTS: G allele carriers showed greater urge to smoke across all assessments. Additionally, a significant interaction indicated that G carriers, compared to homozygotes (AA), evinced a significantly greater increase in urge to smoke after high dose alcohol relative to placebo. The interaction between condition, DRD4 polymorphism, and time was not significant. CONCLUSIONS: Presence of G allele of the A118G polymorphism of the OPRM1 gene may lead to greater increases in urge to smoke after a high dose of alcohol. Pharmacotherapies targeted to opiate receptors (eg, naltrexone) may be especially helpful in aiding smoking cessation among G carriers who are heavy drinkers.
Authors: Melanie L Schwandt; Stephen G Lindell; James D Higley; Stephen J Suomi; Markus Heilig; Christina S Barr Journal: Psychoneuroendocrinology Date: 2011-04-03 Impact factor: 4.905
Authors: Anne M Day; Christopher W Kahler; Nichea S Spillane; Jane Metrik; Damaris J Rohsenow Journal: Addict Behav Date: 2014-02-06 Impact factor: 3.913
Authors: C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu Journal: Proc Natl Acad Sci U S A Date: 1998-08-04 Impact factor: 11.205
Authors: Christina S Barr; Scott A Chen; Melanie L Schwandt; Stephen G Lindell; Hui Sun; Stephen J Suomi; Markus Heilig Journal: Biol Psychiatry Date: 2010-01-01 Impact factor: 13.382
Authors: Daniel J O Roche; Constantine J Trela; Maria Argos; Farzana Jasmine; Muhammad G Kibriya; Habibul Ahsan; Andrea C King Journal: Alcohol Alcohol Date: 2019-01-09 Impact factor: 3.913
Authors: Hiba Alblooshi; Gary Hulse; Wael Osman; Ahmed El Kashef; Mansour Shawky; Hamad Al Ghaferi; Habiba Al Safar; Guan K Tay Journal: Ann Gen Psychiatry Date: 2018-06-01 Impact factor: 3.455